Moreover, different types of gene-based biomarkers such as ARID1A, PIK3CA, KRAS and CTNNB1 are recurrently mutated in endometrial cancer type I, endometriosis and endometriosis-associated ovarian tumors [30]. Here, KRAS is linked to ovarian neoplasm.